Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia

ClinicalTrials.gov ID: NCT05478174

Public ClinicalTrials.gov record NCT05478174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg if needed) is non-inferior to propofol 2.0/1.0 mg/kg (2.0 mg/kg IV slow injection over 30 \[±5\] seconds for first dose, an additional 1.0 mg/kg if needed) in success of induction of general anesthesia in adults undergoing elective surgery.

Study identification

NCT ID
NCT05478174
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
400 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 26, 2022 (Actual)
Primary completion
Nov 7, 2023 (Actual)
Completion
Nov 14, 2023 (Actual)
Last update posted
Oct 10, 2025

2022 – 2023

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Shoals Medical Trials, Inc. Sheffield Alabama 35660 —
Arizona Research Center Phoenix Arizona 85053 —
UC Davis Health Davis California 95616 —
Coastal Clinical Research Specialists Jacksonville Florida 32250 —
University of Miami Hospital Miami Florida 33136 —
Gulfcoast Research Institute, Llc Sarasota Florida 34232 —
Phoenix Clinical Research Tamarac Florida 33321 —
ForCare Clinical Research Tampa Florida 33613 —
Rush University Medical Center Chicago Illinois 60612 —
NextStage Clinical Research - Abay Neuroscience Center Wichita Kansas 67226 —
Chesapeake Research Group, Llc Pasadena Maryland 21122 —
Brigham & Women'S Hospital Boston Massachusetts 02115 —
Duke University Health Durham North Carolina 27710 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Oregon Health & Science University Portland Oregon 97239 —
HD Research Bellaire Texas 77401 —
Hd Research Llc. Carrollton Texas 75006 —
The University of Texas - MD Anderson Cancer Center Houston Texas 77030 —
Urology San Antonio Research San Antonio Texas 78229 —
Endeavor Clinical Trials San Antonio Texas 78240 —
Jbr Clinical Research Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05478174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05478174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →